Johns Hopkins researchers conducted a pilot study to understand how psilocybin affects brain emotion processing and neural circuits in healthy individuals. The 13-participant trial aimed to identify changes that might predict repeated use and reveal the drug's unique abuse liability mechanisms. Unlike traditional addictive substances, classic hallucinogens like psilocybin show atypical patterns of self-administration. This research helps clarify the neurobiological basis of psilocybin's effects on emotional processing, contributing valuable data about safety profiles and abuse potential as psychedelic therapies gain clinical interest for mental health applications.
